Diabetes
Commentary
GLP-1 Receptor Agonists: Which Drug for Which Patient?
Many GLP-1 agonists are available in a diabetes version and a chronic weight management or obesity version.
Conference Coverage
Temporary Gut Liner Lowers Weight, A1c
Two years after the liner’s removal, 80% of patients continued to show significant improvement, while 20% returned to baseline.
News
The Fascinating Way to Measure Glucose With a Phone’s Compass
Proof-of-concept study able to measure glucose to micromolar concentration, similar to CGMs, researchers say.
News
Diabetic Foot Ulcers: Life-Threatening Issue in Need of Help
The 5-year mortality rate for diabetic foot ulcers is 30%, but it climbs to 70% after amputation.
News
Too Little Sleep Raises Health Risks for Teens With T1D
“Sleep may be an important and novel target for improving health in individuals with T1D, particularly when initiated in adolescence or early in...
News
Low-Fat Vegan Diet May Improve Cardiometabolic Health in T1D
The diet, without carbohydrate or portion restrictions, improved glycemic control.
News
GLP-1 Receptor Agonists Don’t Raise Thyroid Cancer Risk
Researchers compared data from 145,410 patients who initiated GLP-1 RAs and 291,667 patients initiating dipeptidyl peptidase 4 (DPP4) inhibitors...
News
Speedy Eating and Late-Night Meals May Take a Toll on Health
Eating too quickly may avoid satiety, allow for overeating, and extend time gastric acids are working, says study.
Conference Coverage
Liquid Biopsy Has Near-Perfect Accuracy for Early Pancreatic Cancer
Researchers develop signature for pancreatic cancer based on microRNAs and cell-free DNA markers in the blood of patients with the disease.
News
Statins Raise Diabetes Risk, but CV Benefit Outweighs It
An analysis of 23 clinical trials found statins could dose-dependently raise the risk of T2D, but CV improvement was more impactful.